3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Metastatic Non-Squamous Non-Small Cell Lung Cancer
1
Melanoma
1
Lung Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Advanced or Metastatic Solid Malignancies
1
Advanced Malignancies
1
Adenocarcinoma
1
Interventions
Doxorubicin
7
pembrolizumab
5
Radiotherapy
5
Specimen Handling
4
Radiation
4
Magnetic Resonance Spectroscopy
4
palbociclib
3
eribulin
3
Ifosfamide
3
Biopsy
3
pazopanib
2
brigimadlin
2
abemaciclib
2
Immunoglobulin G
2
zimberelimab
1
toripalimab
1
talimogene laherparepvec
1
silmitasertib
1
selinexor
1
ribociclib
1
peposertib
1
pemigatinib
1
olaratumab
1
olaparib
1
mirdametinib
1
liposomal doxorubicin
1
lenvatinib
1
enzalutamide
1
durvalumab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
sitravatinib
×
1 year
×
Clear all
No trials found.